Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AZILECT Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"

NCT03727139 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03727139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03727139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AZILECT Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
November 1, 2018
Completion date
October 31, 2021
Enrollment
1,021 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease